Akèy › Sistèm Imunitè ak Twoub › Iowa › Cedar Rapids
Etid klinik pou Sistèm Imunitè ak Twoub nan Cedar Rapids, IA
6 etid pou Sistèm Imunitè ak Twoub ap chèche patisipan nan sit nan ak bò kote Cedar Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- University of Iowa Health, Iowa City · 25 mi lwen
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- The University of Iowa, Iowa City · 25 mi lwen
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- The University of Iowa, Iowa City · 25 mi lwen
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Ap rekriteFaz 1/2
- University of Iowa, Iowa City · 25 mi lwen
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Ap rekriteFaz 3
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi lwen
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Ap rekriteFaz 1/2
- University of Iowa, Iowa City · 25 mi lwen
Etid Sistèm Imunitè ak Twoub nan lòt vil
- Washington, DC13 etid
- New York City, NY12 etid
- Boston, MA10 etid
- Philadelphia, PA10 etid
- Atlanta, GA9 etid
- Portland, OR9 etid
- Houston, TX9 etid
- Cleveland, OH8 etid
- Chicago, IL8 etid
- Los Angeles, CA8 etid
- Milwaukee, WI6 etid
- Seattle, WA6 etid
Lòt etid nan Cedar Rapids
- Kansè Poumon ki pa ti selil20 etid
- Kansè nan tete17 etid
- Leksemi mieloïd egi16 etid
- Kansè (tout kalite)15 etid
- Myelom Miltip15 etid
- Kansè poumon14 etid
- Kansè kolorektal13 etid
- Kansè pwostat12 etid
- Karsinòm selil skuamèz tèt ak kou12 etid
- Melanom10 etid
- Akidan serebavaskilè10 etid
- Kansè Metastatik9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.